Project Details
Description
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Enzalutamide in Subjects with Advanced Hepatocellular Carcinoma
| Status | Finished |
|---|---|
| Effective start/end date | 2/1/16 → 2/28/21 |
Funding
- ASTELLAS PHARMA, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.